全文获取类型
收费全文 | 610篇 |
免费 | 35篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 9篇 |
妇产科学 | 6篇 |
基础医学 | 73篇 |
口腔科学 | 4篇 |
临床医学 | 50篇 |
内科学 | 80篇 |
皮肤病学 | 43篇 |
神经病学 | 8篇 |
特种医学 | 74篇 |
外科学 | 177篇 |
综合类 | 3篇 |
预防医学 | 8篇 |
眼科学 | 63篇 |
药学 | 20篇 |
肿瘤学 | 29篇 |
出版年
2023年 | 4篇 |
2022年 | 2篇 |
2021年 | 9篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 11篇 |
2017年 | 12篇 |
2016年 | 9篇 |
2015年 | 14篇 |
2014年 | 13篇 |
2013年 | 15篇 |
2012年 | 58篇 |
2011年 | 32篇 |
2010年 | 35篇 |
2009年 | 24篇 |
2008年 | 40篇 |
2007年 | 17篇 |
2006年 | 28篇 |
2005年 | 27篇 |
2004年 | 27篇 |
2003年 | 12篇 |
2002年 | 15篇 |
2001年 | 19篇 |
2000年 | 20篇 |
1999年 | 15篇 |
1998年 | 14篇 |
1997年 | 16篇 |
1996年 | 13篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 5篇 |
1992年 | 16篇 |
1991年 | 13篇 |
1990年 | 9篇 |
1989年 | 15篇 |
1988年 | 13篇 |
1987年 | 8篇 |
1986年 | 5篇 |
1985年 | 10篇 |
1984年 | 4篇 |
1983年 | 6篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1973年 | 1篇 |
1972年 | 3篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有647条查询结果,搜索用时 15 毫秒
41.
Solitary bronchioloalveolar carcinoma: CT criteria 总被引:14,自引:0,他引:14
Kuhlman JE; Fishman EK; Kuhajda FP; Meziane MM; Khouri NF; Zerhouni EA; Siegelman SS 《Radiology》1988,167(2):379-382
The computed tomographic (CT) scans of 30 patients with solitary bronchioloalveolar carcinoma were reviewed. Common features at CT included the peripheral or subpleural location of a pulmonary mass (25 cases), pseudocavitation (18 cases), heterogeneous attenuation (17 cases), irregular margins forming a star pattern (22 cases), and pleural tags (21 cases). Using these CT criteria, four independent observers attempted to identify cases of bronchioloalveolar carcinoma from a larger sample of lung cancers and benign lesions by categorizing a series of test cases into four probability categories. Although the bronchioloalveolar carcinomas were correctly ranked in the two highest probability categories 75% of the time (in 45 of 60 cases), there was considerable overlap with other lung lesions, particularly with adenocarcinoma and large cell undifferentiated carcinoma. However, even though the typical features of bronchioloalveolar carcinoma are not invariable or highly specific, they are characteristic enough to suggest the diagnosis. 相似文献
42.
43.
44.
45.
46.
47.
48.
49.
G. Stallone B. Infante P. Pontrelli E. Ranieri A. Loverre A. Schena L. Cormio G. Carrieri F. P. Schena G. Grandaliano L. Gesualdo 《American journal of transplantation》2009,9(3):558-566
The Id-proteins are a family of four related proteins implicated in the control of differentiation and cell-cycle progression. Down-regulation of Id-gene expression is essential for the differentiation of several cell types. In addition, deregulated Id2 activity inhibits the Rb tumor suppressor pathway and promotes the expression of vascular endothelial growth factor (VEGF). Several members of VEGF family could be involved in Kaposi's sarcoma (KS) development and progression. Lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) is the first marker of lymphatic endothelial competence during development in the mature vasculature, and is also expressed on KS spindle cells. Rapamycin (RAPA), an immunosuppressive drug, has been shown to reverse KS growth and to reduce tumor angiogenesis. We evaluate, in transplantation-associated KS and in cultured KS-cells the RAPA effect on Id2 and on de novo lymphangiogenesis. Markers of lymphatic-endothelial-cells (VEGFR-3, LYVE-1) and Id2, expressed at low levels within the normal skin, were up-regulated in KS and returned to normal levels after RAPA introduction. The association between Id2 and lymphangiogenesis is suggested by co-localization of Id2, VEGFR-3 and LYVE-1. RAPA inhibition on Id2 expression was confirmed in vitro in KS-cells, both in basal conditions and upon stimulation with VEGF. In conclusion, our data would suggest a novel molecular mechanism for the antineoplastic effects of RAPA in posttransplant KS. 相似文献
50.
M Heringlake T Kox J Poeling S Klaus T Hanke N Franz F Eberhardt H Heinze FP Armbruster L Bahlmann 《European journal of medical research》2009,14(3):106-112
The insulin-like and vasodilatatory polypeptide relaxin (RLX), formerly known as a pregnancy hormone, has gained interest as a potential humoral mediator in human heart failure. Controversy exists about the relation between plasma levels of RLX and the severity of heart failure. The present study was designed to determine the course of RLX, atrial, and brain natriuretic peptide (NT-proANP and NT-proBNP) during physical exercise in patients with ischemic heart disease (IHD) and to relate hormone levels to peak cardiac power output (CPO) as a measure of cardiopulmonary function with prognostic relevance. 40 patients with IHD were studied during right-heart-catheterization at rest and during supine bicycle ergometry. RLX, NTproBNP, and NTproANP were determined before, during exercise, and after recovery. NT-proANP and NT-proBNP levels increased during maximal charge, and recovery while RLX levels decreased. Cardiac power output at maximal charge correlated inversely with NTproANP and NTproBNP but positively with RLX. Patients with high degree heart failure (CPO < 1.96 W) had higher NTproANP and NTproB-NP and lower RLX levels than patients with low degree heart failure. While confirming the role of NTproANP and NTproBNP as markers for the severity of heart failure, the present data do not support the concept that plasma levels of RLX are related to the severity of myocardial dysfunction and that systemic RLX acts as a compensatory vasodilatatory response hormone in ischemic heart disease. 相似文献